MedTrace Logo

Peer-Delivered Episodic Future Thinking for Returning Citizens

NCT06119503 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-02-25

No results posted yet for this study

Summary

The goal of this study is to examine the effectiveness of a brief, episodic future thinking (EFT) intervention in a substance use treatment setting serving returning citizens with substance use disorders (SUD).

The main questions it aims to answer are:

1. Determine preliminary implementation potential of the EFT intervention, including acceptability and feasibility of conducting the intervention.
2. Examine the preliminary effectiveness of this approach, with a specific focus on patient outcomes, including changes in delay discounting, treatment retention, treatment motivation, and substance use.

Participants will be asked to participant in pre and post assessment questionnaires, participate in a single-episode brief intervention followed by tailored phone call follow-ups.

Conditions

  • Behavior, Health

Interventions

BEHAVIORAL

Elongating Time HOrizons for Reentry (ETHoR)

The adapted episodic future thinking (EFT) intervention will focus on generation of vivid, substance-free, rewarding events that could happen in an incarceration free future.

BEHAVIORAL

Standardized Episodic Thinking (SET)

In the standardized episodic thinking (SET) condition, the participant will instead describe in vivid details events that have occurred in the recent past.

Sponsors & Collaborators

  • Detroit Recovery Project INC

    collaborator UNKNOWN

  • Michigan State University

    collaborator OTHER

  • University of Kansas

    collaborator OTHER

  • Henry Ford Health System

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-11-14
Primary Completion
2024-12-31
Completion
2025-01-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06119503 on ClinicalTrials.gov